These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1562240)
1. Short-term use of carbonic anhydrase inhibitors and hematologic side effects. Fraunfelder FT; Fraunfelder FW Arch Ophthalmol; 1992 Apr; 110(4):446-7. PubMed ID: 1562240 [No Abstract] [Full Text] [Related]
2. Aplastic anemia resulting from the use of carbonic anhydrase inhibitors. Wisch N; Fischbein FI; Siegel R; Glass JL; Leopold I Am J Ophthalmol; 1973 Jan; 75(1):130-2. PubMed ID: 4684255 [No Abstract] [Full Text] [Related]
5. Systemic carbonic anhydrase inhibitors have been used to reduce intraocular pressure in glaucoma patients unresponsive to other anti glaucomatous medical treatments. Jonas JB J Glaucoma; 2001 Oct; 10(5):441. PubMed ID: 11711848 [No Abstract] [Full Text] [Related]
13. [Mode of action, clinical profile and relevance of carbonic anhydrase inhibitors in glaucoma therapy]. Eichhorn M Klin Monbl Augenheilkd; 2013 Feb; 230(2):146-9. PubMed ID: 23430679 [TBL] [Abstract][Full Text] [Related]
14. Principles of medical management in chronic open angle glaucoma. Sugar HS Ann Ophthalmol; 1971 Jun; 3(6):579-86. PubMed ID: 5164431 [No Abstract] [Full Text] [Related]